HIGHLIGHTS
SUMMARY
In response to EIMD, resting muscle µ is increased early ( and amp;lt;1 h) and may remain elevated during the days following ECC (Lacourpaille et_al, 2014; Lacourpaille et_al, 2017; Heales et_al, 2018; Ema et_al, 2021). It can translate into adjustments of structural, neural, and functional properties (Kawakami et_al, 1993; Škarabot et_al, 2021) of the NM system. EIMD results in a defined set of symptoms (e_g, force loss, muscle soreness, stiffness, decrease joint range of motion, increased circulating muscle proteins) consecutive to the disruption of intracellular muscle structure, sarcolemma and extracellular matrix in the days . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.